Nkarta (NKTX) Current Assets (2019 - 2026)
Nkarta's (NKTX) quarterly Current Assets came in at $235.9 million in Q1 2026, down 13.13% year-on-year from $271.6 million in Q1 2025, and down 16.5% quarter-over-quarter from $282.5 million in Q4 2025.
Nkarta (NKTX) Current Assets (2019 - 2026) Analysis & Trends
Nkarta's Current Assets history runs 8 years deep, the most recent figure standing at $235.9 million for Q1 2026.
- On a quarterly basis, Current Assets fell 13.13% year-over-year to $235.9 million in Q1 2026; TTM through Mar 2026 was $235.9 million, a 13.13% decrease from a year earlier, with the FY2025 full-year figure at $282.5 million, up 3.36% from the prior year.
- Current Assets retreated to $235.9 million in Q1 2026 per NKTX's latest filing, from $282.5 million in the prior quarter.
- Across five years, Current Assets topped out at $442.8 million in Q1 2024 and bottomed at $223.2 million in Q1 2022.
- The 5-year median for Current Assets is $289.3 million (2025), against an average of $310.0 million.
- Across the five-year window, Current Assets soared 51.5% in 2022 and tumbled 38.67% in 2025, its largest moves.
- Year by year, Current Assets stood at $360.7 million in 2022, then fell by 29.84% to $253.1 million in 2023, then increased by 8.01% to $273.3 million in 2024, then climbed by 3.36% to $282.5 million in 2025, then decreased by 16.5% to $235.9 million in 2026.
- Per Business Quant, the three latest NKTX Current Assets figures stand at $235.9 million (Q1 2026), $282.5 million (Q4 2025), and $289.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - | 235.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 235.89 Mn |
| Dec 31, 2025 | 282.51 Mn |
| Sep 30, 2025 | 289.28 Mn |
| Jun 30, 2025 | 296.57 Mn |
| Mar 31, 2025 | 271.55 Mn |
| Dec 31, 2024 | 273.34 Mn |
| Sep 30, 2024 | 290.15 Mn |
| Jun 30, 2024 | 331.80 Mn |
| Mar 31, 2024 | 442.78 Mn |
| Dec 31, 2023 | 253.07 Mn |
| Sep 30, 2023 | 281.19 Mn |
| Jun 30, 2023 | 286.74 Mn |
| Mar 31, 2023 | 332.19 Mn |
| Dec 31, 2022 | 360.69 Mn |
| Sep 30, 2022 | 400.92 Mn |
| Jun 30, 2022 | 417.38 Mn |
| Mar 31, 2022 | 223.22 Mn |
| Dec 31, 2021 | 245.78 Mn |
| Sep 30, 2021 | 264.64 Mn |
| Jun 30, 2021 | 283.94 Mn |